Home > Financial Ratios > AURO LABORATORIES

AURO LABORATORIES
Core EBITDA Growth

    Back to All Ratios
COMMUNITY POLL
for AURO LABORATORIES
Please provide your vote to see the results

AURO LABORATORIES Last 5 Year Core EBITDA Growth History

[Standalone]

Mar2026Mar2025Mar2024Mar2023Mar2022
   Core EBITDA Growth(%) 195.98-66.65128.22-6.71-52.35

What is the latest Core EBITDA Growth ratio of AURO LABORATORIES ?

The latest Core EBITDA Growth ratio of AURO LABORATORIES is 195.98 based on Mar2026 Standalone results.
Year Core EBITDA Growth
Mar2026195.98
Mar2025-66.65
Mar2024128.22
Mar2023-6.71
Mar2022-52.35

How is Core EBITDA Growth of AURO LABORATORIES Trending?

Years Core EBITDA Growth % Change
Mar2026 195.98
Positive
Mar2025 -66.65
Negative
Mar2024 128.22
Positive
Mar2023 -6.71
Negative
Mar2022 -52.35 -

Other Financial Ratios of AURO LABORATORIES


Compare Core EBITDA Growth ratio of peers of AURO LABORATORIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
AURO LABORATORIES ₹145.0 Cr 0.8% -4.1% -6.2% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹458,249.0 Cr 1.8% -1.6% 16.5% Stock Analytics
DIVIS LABORATORIES ₹225,648.0 Cr -1.2% 17.3% 38.7% Stock Analytics
TORRENT PHARMACEUTICALS ₹184,891.0 Cr -2.3% -2% 33.6% Stock Analytics
CIPLA ₹115,927.0 Cr 0.2% 1.7% -8.8% Stock Analytics
DR REDDYS LABORATORIES ₹99,702.0 Cr 1.2% 3.6% -7% Stock Analytics


AURO LABORATORIES Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
AURO LABORATORIES

0.8%

-4.1%

-6.2%

SENSEX

-0.5%

1.3%

-4%


You may also like the below Video Courses